Page last updated: 2024-10-18

glycine and Diffuse Parenchymal Lung Disease

glycine has been researched along with Diffuse Parenchymal Lung Disease in 7 studies

Research Excerpts

ExcerptRelevanceReference
"Many of these patients die from interstitial lung disease despite discontinuation of the drug and addition of corticosteroid treatment."2.40[Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation]. ( Ishioka, S, 1997)
"However, interstitial lung disease (ILD) is a very rare yet potentially fatal complication of RTX treatment."1.48Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. ( Ahn, SH; Kim, SM; Sung, JJ, 2018)
"Respiratory failure was relieved within 2 weeks following treatment There was no four-fold rise in screen viral titers and screening investigations of autoantibodies were negative."1.33[Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy]. ( Chida, K; Enomoto, N; Imokawa, S; Nagayama, M; Sano, T; Suda, T; Todate, A; Uchiyama, H; Yasuda, K, 2006)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Ito, H1
Nakayama, H1
Yokose, T1
Nagashima, T1
Morohoshi, T1
Tajiri, M1
Maehara, T1
Watanabe, K1
Arai, H1
Yamamoto, T1
Woo, T1
Nishii, T1
Ishikawa, Y1
Morita, S1
Masuda, M1
Ahn, SH1
Kim, SM1
Sung, JJ1
Sakai, M1
Takenami, T1
Otsuka, T1
Hayashi, N1
Yoshino, K1
Matsumoto, S1
Okamoto, H1
Imokawa, S1
Sano, T1
Todate, A1
Uchiyama, H1
Yasuda, K1
Nagayama, M1
Enomoto, N1
Suda, T1
Chida, K1
Morooka, T1
Morioka, M1
Nomura, Y1
Furuya, H1
Kobayashi, J1
Kitamura, S1
Ishioka, S1

Reviews

2 reviews available for glycine and Diffuse Parenchymal Lung Disease

ArticleYear
[How can we monitor and treat patients with acute exacerbations of idiopathic interstitial pneumonia].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34 Suppl

    Topics: Acute-Phase Reaction; Anti-Inflammatory Agents; Antigens; Antigens, Neoplasm; Biomarkers; Clinical T

1996
[Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24 Suppl 3

    Topics: Animals; Antineoplastic Agents; Bleomycin; Drug Administration Schedule; Glycine; Humans; Lung Disea

1997

Trials

1 trial available for glycine and Diffuse Parenchymal Lung Disease

ArticleYear
A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery.
    Japanese journal of clinical oncology, 2020, Feb-17, Volume: 50, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Female; Glycine; Humans; Lung; Lung Diseases, Interstitial; Lung Neo

2020

Other Studies

4 other studies available for glycine and Diffuse Parenchymal Lung Disease

ArticleYear
Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
    Multiple sclerosis and related disorders, 2018, Volume: 20

    Topics: Aquaporin 4; Autoantibodies; Female; Glycine; Humans; Immunoglobulin G; Immunologic Factors; Lung Di

2018
[Anesthetic management of posterior lumbar spinal fusion in a patient suspected of having acute exacerbation of chronic interstitial pneumonia].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:2

    Topics: Acute-Phase Reaction; Aged; Airway Management; Anesthesia; Chronic Disease; Disease Progression; Eme

2014
[Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:1

    Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Glycine; Humans; Lung Diseases, Interstitial

2006
[Case of fulminant idiopathic interstitial pneumonia treated by sodium siverlestat (Elaspol) and steroid pulse therapy following extracorporeal lung assist (ECLA)].
    Masui. The Japanese journal of anesthesiology, 2007, Volume: 56, Issue:10

    Topics: Extracorporeal Membrane Oxygenation; Glycine; Humans; Lung Diseases, Interstitial; Male; Methylpredn

2007